Strong efficacy of LipiFlow demonstrated across 31 peer-reviewed reports Long-term efficacy of a single LipiFlow procedure evaluated and reported in both sponsored and independent studies MORRISVILLE, N.C. ─ September 8, 2015 ─ TearScience , a privately...

TearScience® Achieves Korean HIRA Approval TearScience’s LipiFlow® Receives HIRA Patient Payment Approval, Paving the Way to Commercial Launch in Korea MORRISVILLE, N.C.,—May 19, 2014—TearScience®, Inc., a privately held medical device company, today...